Leo Francesco, Venissac Nicolas, Pop Daniel, Solli Piergiorgio, Filosso Pierluigi, Minniti Antonio, Radice Davide, Mouroux Jérôme, Spaggiari Lorenzo, Pastorino Ugo, Jougon Jacques, Velly Jean Francois, Oliaro Alberto
Thoracic Surgery Department, European Institute of Oncology, Milan, Italy.
Eur J Cardiothorac Surg. 2008 Mar;33(3):424-9. doi: 10.1016/j.ejcts.2007.11.024. Epub 2008 Jan 15.
One of the characteristics of chronic obstructive pulmonary disease (COPD) is the tendency to develop acute exacerbation, defined by the presence of different clinical findings as worsening dyspnea, increase in sputum purulence and volume. This study was designed to verify if definition of acute COPD exacerbation is applicable to patients who underwent pulmonary surgery, and if it has any impact on postoperative morbidity and mortality.
This study was designed to prospectively enrol 1000 patients undergoing pulmonary resection for lung cancer from five different centres. Postoperative exacerbation of COPD was defined by the concomitant presence of three of the following five signs: deteriorating dyspnea, purulent sputum, bronchial secretion volume >10 ml/24 h, fever without apparent cause, and wheezing. The presence of concomitant pulmonary complications excluded the diagnosis of exacerbation, as they may present one or more of these signs.
In the absence of respiratory complications, postoperative stay in exacerbated patients was significantly longer as compared to patients without exacerbation (6.3+/-1.3 vs 8.3+/-1.1, p=0.001). A postoperative exacerbation of COPD was recorded in 276 patients and 152 of them (55%) subsequently developed respiratory complications. Multivariate analysis established that risk factors for postoperative exacerbation are sex (female OR 0.54, CI 0.2-0.8), COPD class (OR 1.5, CI 1.1-8.1), and the postoperative prolonged use of antibiotics (OR 0.6, CI 0.2-0.9).
Postoperative exacerbation of COPD is an existing, frequent clinical entity after lung resection and, when present, it increases the risk of pulmonary complications. The existing guidelines for the treatment of acute exacerbation should be adapted for the management of patients after lung resection in order to test the hypothesis that they could reduce respiratory morbidity.
慢性阻塞性肺疾病(COPD)的特征之一是易于发生急性加重,其定义为出现不同的临床症状,如呼吸困难加重、痰液脓性及量增加。本研究旨在验证COPD急性加重的定义是否适用于接受肺部手术的患者,以及它是否对术后发病率和死亡率有任何影响。
本研究旨在前瞻性纳入来自五个不同中心的1000例因肺癌接受肺切除术的患者。COPD术后加重定义为同时出现以下五个体征中的三个:呼吸困难恶化、脓性痰、支气管分泌量>10 ml/24小时、无明显原因的发热和喘息。合并肺部并发症的存在排除了加重的诊断,因为它们可能表现出这些体征中的一个或多个。
在没有呼吸并发症的情况下,与未加重的患者相比,加重患者的术后住院时间明显更长(6.3±1.3天对8.3±1.1天,p = 0.001)。276例患者记录有COPD术后加重,其中152例(55%)随后发生呼吸并发症。多变量分析确定术后加重的危险因素为性别(女性OR 0.54,CI 0.2 - 0.8)、COPD分级(OR 1.5,CI 1.1 - 8.1)和术后长期使用抗生素(OR 0.6,CI 0.2 - 0.9)。
COPD术后加重是肺切除术后存在的、常见的临床情况,一旦出现,会增加肺部并发症的风险。现有的急性加重治疗指南应适用于肺切除术后患者的管理,以检验它们能否降低呼吸发病率这一假设。